Lindus Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
80
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$55.2M
- Investors
-
29
Lindus General Information
Description
Developer of an artificial intelligence-native biopharmaceutical company designed to identify, develop, and advance drug candidates through clinical development. The company offers asset identification and selection capabilities, in-licensed drug development programs, integrated clinical trial management, and expert-led development supported by proprietary artificial intelligence systems, enabling biopharmaceutical companies and research partners to advance drug candidates more efficiently and reach key clinical development milestones.
Contact Information
Website
www.lindustx.comCorporate Office
- 65 Southwark Street
- 1st and 2nd Floors
- London SE1 0HR
- England, United Kingdom
Corporate Office
- 65 Southwark Street
- 1st and 2nd Floors
- London SE1 0HR
- England, United Kingdom
Lindus Timeline
Lindus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC (Series B) | 22-Jan-2025 | $55.2M | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | 10-Sep-2024 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 09-Aug-2023 | Completed | Generating Revenue | |||
| 3. Grant | 17-May-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series 3) | 08-Nov-2021 | $8.48M | $8.48M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue |
Lindus Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B Preferred | ||||||||
| Series A-2 Preferred | ||||||||
| Series A-1 Preferred | ||||||||
| Preference | 659,361 | $0.000001 | $6 | $6 | 1x | $6 | 13.74% | |
| Preference | 43,237 | $0.000001 | $5.1 | $5.1 | 1x | $5.1 | 0.9% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Lindus Comparisons
Industry
Financing
Details
Lindus Competitors (10)
One of Lindus’s 10 competitors is Formation Bio, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Formation Bio | Venture Capital-Backed | New York, NY | ||||
| Roche | Corporation | Basel, Switzerland | ||||
| Roivant Sciences | Formerly PE-Backed | New York, NY | ||||
| Vial (Drug Discovery) | Venture Capital-Backed | San Francisco, CA | ||||
| Novartis | Corporation | Basel, Switzerland |
Lindus Signals
Lindus Investors (29)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Balderton Capital | Venture Capital | Minority | ||
| SC Nation Services | Venture Capital | Minority | ||
| Visionaries Club | Venture Capital | Minority | ||
| Tech Nation Group | Accelerator/Incubator | |||
| 271.vc | Venture Capital | Minority |
Lindus FAQs
-
When was Lindus founded?
Lindus was founded in 2021.
-
Where is Lindus headquartered?
Lindus is headquartered in London, United Kingdom.
-
What is the size of Lindus?
Lindus has 80 total employees.
-
What industry is Lindus in?
Lindus’s primary industry is Biotechnology.
-
Is Lindus a private or public company?
Lindus is a Private company.
-
What is the current valuation of Lindus?
The current valuation of Lindus is .
-
What is Lindus’s current revenue?
The current revenue for Lindus is .
-
How much funding has Lindus raised over time?
Lindus has raised $81.3M.
-
Who are Lindus’s investors?
Balderton Capital, SC Nation Services, Visionaries Club, Tech Nation Group, and 271.vc are 5 of 29 investors who have invested in Lindus.
-
Who are Lindus’s competitors?
Formation Bio, Roche, Roivant Sciences, Vial (Drug Discovery), and Novartis are some of the 10 competitors of Lindus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process